 The Institute of Translational Health Sciences, ITHS, has seen success in its efforts to facilitate the translation of research discoveries into medical products through its Drug and Device Advisory Committee, DDAC. Since its establishment in 2008, the DDAC has provided product-specific scientific and regulatory mentoring to investigators seeking to translate their discoveries into medical products. This has resulted in 161 unique project teams being supported, 28% of which have gone on to form startups. Additionally, the commercialization rate for the UW School of Medicine increased significantly after the integration of the DDAC into the commercialization programs offered by the university's Technology Transfer Office. This article was authored by Lynn M. Reyes, Fiona Wills, Connie Barrassassure, and others.